Disseminated intravascular coagulation after endovascular aneurysm repair: Resolution after aortic banding  by Patel, Ashish S. et al.
Disseminated intravascular coagulation after
endovascular aneurysm repair: Resolution after
aortic banding
Ashish S. Patel, MRCS (Eng), MBBS (Lond), BSc (Hons),a Rachel Bell, MS, FRCS,a
Beverley J. Hunt, FRCP, FRCPath, MD,b and Peter R. Taylor, MA, Mchir, FRCS,a London, United Kingdom
Disseminated intravascular coagulation (DIC) has been shown to affect 2% to 4% of patients with abdominal aortic
aneurysms. In rare cases of DIC caused by aneurysms, operative repair has been curative. Endovascular aneurysm repair
(EVAR) has been established as an effective treatment. We report a 73-year-old man in whom severe bleeding developed
from groin incisions and cannulae sites immediately after EVAR. An intraoperative angiogram showed a type I endoleak,
but the procedure had to be abandoned due to continued bleeding. Blood tests confirmed a diagnosis of disseminated
intravascular coagulation that persisted chronically 3 months postoperatively. Attempts to repair the endoleak with
stenting were unsuccessful, resulting in persistence of disseminated intravascular coagulation. This resolved after
successful treatment of the endoleak with aortic banding. (J Vasc Surg 2009;49:1046-9.)Disseminated intravascular coagulation (DIC) as a
result of endoleaks after endovascular aneurysm repair
(EVAR) has been reported, and very rare cases of treatment
of DIC after repair of these endoleaks have been described.
We present, to our knowledge, the first description of aortic
banding to successfully treat endoleak-associated DIC.
CASE REPORT
A 73-year-old man was admitted for an endovascular repair of a
6.4-cm asymptomatic abdominal aortoiliac aneurysm. His medical
history included ischemic heart disease, hypertension, hyperlipidemia,
and coronary artery bypass grafting 5 years previously. He was taking
aspirin (75 mg), simvastatin (20 mg), and candesartan (8 mg) daily
preoperatively. He was an ex-smoker, had no history of excessive
alcohol intake, and was fully independent. Three-dimensional recon-
structions of his computed tomography (CT) scan were obtained
before his procedure. The right internal iliac artery was embolized a
month before this endovascular aneurysm repair (EVAR).
The EVAR was performed under epidural anesthesia. The
patient received 5000 U of unfractionated heparin intravenously
intraoperatively. A bifurcated Zenith (Cook, Bloomington, Ind)
endovascular graft device was deployed to the common iliac artery
on the left and the external iliac artery on the right. Completion
angiography demonstrated a proximal type I endoleak (Fig 1).
At this time, he was noted to be bleeding from both groin
incisions as well as the epidural and cannula sites. His platelet
count, which had been low at 108  109/L preoperatively, fell to
46  109/L. Other variables were Clauss fibrinogen, 1.01, D-
dimers, 29 mg/L (normal range, 0-0.25 mg/L), international
normalized ratio (INR), 1.31 (compared with 0.98 preopera-
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1046tively), activated partial thromboplastin time (APTT) ratio, 1.18;
hemoglobin,10.9 g/dL; mean corpuscular volume, 102 fL; and
white cell count, 7.3 109/L.
No attempt was made to seal the proximal endoleak because
the bleeding continued and he remained hemodynamically unsta-
ble. He was given a transfusion of 4 U of packed red cells and 2
pools of platelets. Despite this, his platelet count remained persis-
tently low during the following days (between 51 and 70 109/L).
A hematinic screen confirmed low serum iron, folate, and B12 con-
centrations, and he was started on appropriate supplements. Analysis
of a bone marrow aspiration and trephine showed mild dyserythro-
poiesis but no macro megakaryocytes to indicate myelodysplasia or
features of idiopathic thrombocytopenic purpura.
A routine 3-month follow-up CT scan demonstrated the
persisting type I proximal endoleak (Fig 2), and he was readmitted
for insertion of Palmaz stents (Cordis, Miami Lakes, Fla) to correct
this. His coagulation profile before this procedure was still abnor-
mal (platelets, 56  109/L; Clauss fibrinogen, 1.32; INR, 1.02),
and a blood film indicated true thrombocytopenia. His D-dimer
levels remained high at 4.45 mg/L, and a diagnosis of chronic
disseminated intravascular coagulopathy wasmade.Hewas given 2
pools of platelets and cryoprecipitate before this procedure.Hewas
given 5000 U of unfractionated intravenous heparin intraopera-
tively, but a persistent type I endoleak was noted despite successful
deployment of the Palmaz stents.
The patient then underwent banding of the proximal aortic
neck under general anesthesia 3 months later. His preoperative
coagulation screen was platelets, 27  109/L; Clauss fibrinogen,
1.12; and INR, 1.09. Once again, he required 2 pools of platelets
before the procedure to correct the thrombocytopenia. Six days
after successful banding, his coagulation profile had returned to
within normal limits (INR, 1.01; Clauss fibrinogen, 4.92), but his
platelets remained low (34 109/L). His platelet levels recovered
within a few weeks, and at the 3-month follow-up, a CT scan
confirmed that the endoleak had been successfully sealed (Fig 3),
and he had a normal full blood count, with a platelet count of
184  109/L and normal coagulation screen. To date, his current
follow-up period is 18 months, and there has been no evidence of
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scanning. Fig 4 shows a graph of his platelet counts during this
period.
DISCUSSION
DIC is a syndrome where nonphysiologic stimulation of
coagulation leads to inappropriate activation of hemostasis
with thrombosis and consumption of coagulation factors and
platelets such that there is increased bleeding risk. Laboratory
assays reveal thrombocytopenia, prolongation of INR or
APTT, and reduction of fibrinogen. Activation of coagulation
leads to increasedfibrinolysis, due to thrombin stimulating the
release of tissue plasminogen activator, such that there are
increased levels of fibrin-derived products (FDPs) such as
D-dimers. The specific pathophysiology ofDIC in this setting
Fig 1. Angiogram shows a proximal type I endoleak (arrow).
Fig 2. A computed tomography scan shows a proximal type I
endoleak.probably relates to the exposure of the blood to tissue factorand denuded aortic endothelial surface, resulting in continued
stimulation of coagulation.1
Studies have shown DIC occurs in 2% to 4% of patients
with aortic aneurysms.2,3 In rare cases of DIC caused by
abdominal aortic aneurysms, operative repair has been cur-
ative.4 Few studies have focused on endovascular treat-
ment; by excluding the aneurysm sac from the circulation,
there is no further thrombotic stimulus. Monaco et al5
concluded that EVAR leads to activation of coagulation
and fibrinolysis with a significant decrease in the level of
platelets, fibrinogen, plasminogen, and prothrombin activity
along with a substantial increase in FDP and D-dimer levels.
These abnormalities resolved within a month, however, and
had no effect on early outcome or midterm follow-up.
Shimazaki et al6 also found activation of coagulation and the
fibrinolytic system on day 1 after EVAR, but all factors re-
turned to preoperative levels by day 3 and no patients exhib-
ited a postoperative consumptive coagulopathy.
These abnormalities after EVAR seem to be transient
and clinically quiescent, but fatalities have been reported as
a result of overwhelming DIC from an otherwise uncom-
plicated EVAR.7,8 Our patient had a significant decrease in
platelet levels and a corresponding increase in coagulation
time and levels of FDPs to suggest the onset of DIC
immediately after EVAR. The platelet count remained low,
and FDP levels were consistently raised until successful
aortic banding, after which they returned to normal limits
just 2 weeks after the procedure (Fig 4).
Endoleaks have been reported to cause postoperative
DIC.9,10 The chronic DIC in our patient was likely due to
continued endoleak-related perfusion of the aneurysm sac,
which would therefore fail to thrombose. This resulted in
constant exposure of blood to denuded endothelium and
tissue factor, causing a consumption of clotting factors.
Also, the shear stresses of blood flowing through an area of
Fig 3. A computed tomography scan shows successful seal of the
endoleak.turbulence would case intravascular hemolysis. The inner
ts pla
JOURNAL OF VASCULAR SURGERY
April 20091048 Patel et alsurface of the red cell membrane is rich in negatively
charged phospholipids, which would also promote activa-
tion of coagulation. Keo et al10 described endovascular
stent graft extension to treat DIC caused by a type I
endoleak after EVAR, and they too postulated liberation of
tissue factors from the turbulent jet flow into the circulation
as the possible mechanism of DIC.
The cell-based model of hemostasis proposes that coagu-
lation takes place on different cell surfaces in three overlapping
steps: initiation, amplification, and propagation, but is driven
by the initial exposure of tissue factor.11 Platelets, factor VII,
and von Willebrand factor (vWF) come into contact with
thrombin on the surface of tissue factor-bearing cells. This
thrombin activates platelets, and factor VIII, factor V, and
factor XI–continued exposure of tissue factor could result in
the DIC seen in endoleaks.
In our patient, multiple attempts at stent graft exten-
sion failed to seal the type I endoleak, and the hemostatic
profile showed that the patient continued to have a
chronic low-grade DIC. Palmaz stenting and periaortic
ligatures are feasible techniques for the treatment of
proximal endoleaks, although the perioperative mortal-
ity of periaortic ligatures is higher compared with other
less invasive techniques.12 Cummins et al13 showed that
long-term treatment with low-molecular-weight heparin
(dalteparin) in a patient with an aortic dissection who
was unfit for open surgery provided symptomatic control
Fig 4. Graph presenof chronic DIC.In conclusion, we report, to our knowledge, the first
case of aortic banding to successfully treat an endoleak that
corrected a chronic low-grade DIC.
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